Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1999
03/18/1999WO1999012947A1 6,9-bridged erythromycin derivatives
03/18/1999WO1999012944A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
03/18/1999WO1999012936A1 Furopyrrolidine derivatives and their use as serine protease inhibitors
03/18/1999WO1999012935A1 Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors
03/18/1999WO1999012934A1 Pyrrolopyrrolone derivatives
03/18/1999WO1999012933A2 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012932A1 Method of inhibiting serine protease enzymes
03/18/1999WO1999012931A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012930A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999WO1999012928A1 3-(iodophenoxymethyl) carbapenem antibacterials
03/18/1999WO1999012927A1 Purine acyclonucleosides as antiviral agents
03/18/1999WO1999012926A1 Tetrahydro gamma-carbolines
03/18/1999WO1999012924A1 Piperidinylmethyloxazolidinone derivative
03/18/1999WO1999012923A1 Stereoisomeric indole compounds, process for the preparation of the same, and use thereof
03/18/1999WO1999012921A1 Thromboxane ligands
03/18/1999WO1999012919A1 Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors
03/18/1999WO1999012918A1 Tryptase inhibitor
03/18/1999WO1999012917A1 Ureido and thioureido derivatives of 4-amino-2(5h)-furanones and 4-amino-2(5h)-thiophenones as antitumor agents
03/18/1999WO1999012916A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999WO1999012915A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999WO1999012912A1 Thiourea derivatives or non-toxic salts thereof for inhibitng ras-transformed cell growth
03/18/1999WO1999012908A1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity
03/18/1999WO1999012905A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999WO1999012903A1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
03/18/1999WO1999012901A1 Substituted 2-pyrrolidinone activators of pkc
03/18/1999WO1999012898A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
03/18/1999WO1999012896A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
03/18/1999WO1999012895A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
03/18/1999WO1999012894A1 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
03/18/1999WO1999012891A1 Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them
03/18/1999WO1999012875A1 Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
03/18/1999WO1999012640A1 Coated particles, methods of making and using
03/18/1999WO1999012570A2 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
03/18/1999WO1999012567A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012554A1 Chemical supplementation of bone
03/18/1999WO1999012552A1 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
03/18/1999WO1999012551A1 Method of increasing bone volume using non-naturally-occurring fp selective agonists
03/18/1999WO1999012550A1 Method of increasing bone volume
03/18/1999WO1999012549A2 Controlled release microsphere delivery system
03/18/1999WO1999012548A1 Treatment of inflammatory conditions
03/18/1999WO1999012547A1 Treatment of inflammatory conditions
03/18/1999WO1999012546A1 Remedial agent for neural degeneration
03/18/1999WO1999012544A1 Intranasal formulation containing scopolamine and method of treating motion sickness
03/18/1999WO1999012543A1 Dithiolopyrrolones and their corresponding monoxides and dioxides as antineoplastic agents
03/18/1999WO1999012542A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
03/18/1999WO1999012541A1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces
03/18/1999WO1999012539A1 The use of an nadph-oxidase inhibitor in the treatment of reperfusion injury
03/18/1999WO1999012538A1 Liver fat accumulation inhibitory composition, food additive for liver fat accumulation inhibition, and method of inhibiting liver fat accumulation
03/18/1999WO1999012537A1 Analgesic compositions comprising anti-epileptic compounds and methods of using same
03/18/1999WO1999012536A1 Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia
03/18/1999WO1999012535A1 Use of sulphonamide benzene derivatives to obtain a medicine for treating retrograde ejaculation or aspermia
03/18/1999WO1999012533A1 A method of modulating cellular activity
03/18/1999WO1999012532A2 Piperidine derivatives against malaria
03/18/1999WO1999012531A2 Hormonal contraceptive
03/18/1999WO1999012529A2 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
03/18/1999WO1999012524A1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1999012520A1 Compositions adapted for prolonged residence in the nasal pharynx
03/18/1999WO1999012431A1 Animal feed containing carboxylic acids
03/18/1999WO1999012414A1 Transplacental delivery of oligonucleotides
03/18/1999WO1998058635A3 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis
03/18/1999WO1998058634A3 Intratumoral administration of triphenylethylenes for the treatment of cancer
03/18/1999WO1998058629A3 Preparation of pharmaceutical compositions
03/18/1999WO1998057937A3 Inhibitors of factor xa with a neutral p1 specificity group
03/18/1999WO1998057620A3 Inositol for modulation of immune response
03/18/1999WO1998052614A3 Composition and method for enhancing transport across biological membranes
03/18/1999WO1998044103A3 Protein for inhibiting apoptosis
03/18/1999WO1998008481A3 Process and apparatus for the production of bi-212 and a use thereof
03/18/1999DE19740571C1 Antigen-specific stimulation of T cells
03/18/1999DE19740285A1 Hair treatment emulsion used e.g. setting lotion, treatment, shampoo or conditioner
03/18/1999DE19740110A1 New hydroxy substituted benzomorphan derivatives
03/18/1999DE19739916A1 Mittel zur hormonalen Kontrazeption Means for hormonal contraception
03/18/1999DE19737224A1 Pharmaceutical preparation for cardiovascular treatment
03/18/1999CA2569685A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999CA2303800A1 Method of increasing bone volume using non-naturally-occurring fp selective agonists
03/18/1999CA2303799A1 Method of increasing bone volume
03/18/1999CA2303616A1 Transplacental delivery of oligonucleotides
03/18/1999CA2303444A1 Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
03/18/1999CA2303443A1 Compositions adapted for prolonged residence in the nasal pharynx
03/18/1999CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999CA2303438A1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
03/18/1999CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999CA2303347A1 Chemical supplementation of bone
03/18/1999CA2303249A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303248A1 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
03/18/1999CA2303176A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999CA2303146A1 Substituted 2-pyrrolidinone activators of pkc
03/18/1999CA2302762A1 Controlled release microsphere delivery system
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2302687A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
03/18/1999CA2302630A1 Purine acyclonucleosides as antiviral agents
03/18/1999CA2302555A1 Thromboxane ligands
03/18/1999CA2302470A1 Synthetic divalent slex containing polylactosamines and methods for use
03/18/1999CA2302284A1 Ureido and thioureido derivatives of 4-amino-2(5h)-furanones and 4-amino-2(5h)-thiophenones as antitumor agents
03/18/1999CA2302148A1 Human papilloma virus inhibition by anti-sense oligonucleotides
03/18/1999CA2302009A1 3-(iodophenoxymethyl) carbapenem antibacterials
03/18/1999CA2301979A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999CA2301969A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
1 ... 6525 6526 6527 6528 6529 6530 6531 6532 6533 6534 6535 6536 6537 6538 6539 6540 6541 6542 6543 6544 6545 ... 7860